Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| Balanced Scorecard στην Υγεία× | Ανάλυση Κόστους-Αποτελεσματικότητας στην Αξιολόγηση Τεχνολογιών Υγείας (HTA)× | |
|---|---|---|
| Πεδίο | Διοίκηση Υπηρεσιών Υγείας | Διοίκηση Υπηρεσιών Υγείας |
| Οικογένεια | Process / pipeline | Process / pipeline |
| Έτος προέλευσης≠ | 1992 | 1996 |
| Δημιουργός≠ | Robert Kaplan, David Norton | Diane Meade Drummond, Michael Gold |
| Τύπος≠ | Strategic planning and management framework | Economic evaluation methodology |
| Θεμελιώδης πηγή≠ | Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard: Measures that drive performance. Harvard Business Review, 70(1), 71–79. DOI ↗ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 |
| Εναλλακτικές ονομασίες | Healthcare BSC, Balanced Scorecard Healthcare | CEA, Cost-Effectiveness Analysis Healthcare |
| Συναφείς | 5 | 5 |
| Σύνοψη≠ | The Balanced Scorecard is a strategic performance management framework that translates an organization's mission and strategy into a comprehensive set of performance measures across four perspectives: financial, customer, internal processes, and learning and growth. Developed by Kaplan and Norton in 1992 for general business, it has been extensively adapted for healthcare organizations to align hospital operations with strategic objectives. | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|